Studies
Primary studies
26,293 studies included by 1,022 non-Cochrane dental reviews extracted from full text, one record per study, so a study included by several reviews is counted once. Most are randomized trials; etiology and diagnostic reviews also include observational and accuracy studies. Cochrane reviews and reviews with only their headline outcomes do not list their included studies here yet.
ReviewStudies included by Two-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis.. Show all studies
| Study | Year | Reviews | Review outcomes linked | Trial data |
|---|---|---|---|---|
| Neoadjuvant immunoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma: a retrospective study. Shen 2022 · Shen Peng, Qiao Bo, et al. · Investigational new drugs PMID:35972629 | 2022 | 2 | none stated | not extracted yet |
| Neoadjuvant chemoimmunotherapy in resectable locally advanced oral squamous cell carcinoma: a single-center retrospective cohort study. Li 2024 · Li Bowen, Xie Shule, et al. · International journal of surgery (London, England) PMID:38935124 | 2025 | 1 | none stated | not extracted yet |
| Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: Randomized, two-arm, phase 2 trial. Liu 2025 · Liu Hai-Ming, Xiong Xue-Peng, et al. · Cell reports. Medicine PMID:39889711 | 2025 | 1 | none stated | not extracted yet |
| Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma. Yamakawa 2022 · Yamakawa Nobuhiro, Umeda Masahiro, et al. · Oral diseases PMID:36519515 | 2024 | 1 | none stated | not extracted yet |
| Higher overall survival rates of oral squamous cell carcinoma treated with metronomic neoadjuvant chemotherapy. Kina 2024 · Kina Shinichiro, Miyamoto Sho, et al. · American journal of cancer research PMID:38590400 | 2024 | 1 | none stated | not extracted yet |
| A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma. Ju 2023 · Ju Houyu, Wei Dongliang, et al. · MedComm PMID:37492783 | 2023 | 1 | none stated | not extracted yet |
| Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion. Stanford-Moore 2022 · Stanford-Moore Gaelen B, Sola Ana Marija, et al. · American journal of otolaryngology PMID:34894450 | 2022 | 1 | none stated | not extracted yet |
| Multicenter Retrospective Study of Weekly Cetuximab Plus Paclitaxel for Recurrent or Metastatic Oral Squamous Cell Carcinoma. Naruse 2021 · Naruse Tomofumi, Yanamoto Souichi, et al. · Anticancer research PMID:34732452 | 2021 | 1 | none stated | not extracted yet |
| Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with… Kashyap 2021 · Kashyap Lakhan, Patil Vijay, et al. · Ecancermedicalscience PMID:35211194 | 2021 | 1 | none stated | not extracted yet |
| Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score… Yoshida 2020 · Yoshida Ryoji, Nagata Masashi, et al. · PloS one PMID:32294127 | 2020 | 1 | none stated | not extracted yet |